DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks

Information source: The University of Texas Medical Branch, Galveston
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Burn

Intervention: Sulfamylon 5% and Silver Nitrate Soaks (Drug)

Phase: Phase 2/Phase 3

Status: Terminated

Sponsored by: The University of Texas Medical Branch, Galveston

Official(s) and/or principal investigator(s):
David N Herndon, MD, Principal Investigator, Affiliation: University of Texas


Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).

Clinical Details

Official title: Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds

Study design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Infection Rate

Secondary outcome: Length of Hospital Stay With Various Antimicrobial Solutions for Burn Patients

Detailed description: Patients were treated with both Sulfamylon soaks and Silver nitrate soaks on different burn areas. These two areas were then compared for incidence (percentage) of infections.


Minimum age: N/A. Maximum age: 90 Years. Gender(s): Both.


Inclusion Criteria:

- Burn Injury requiring excisional therapy

- Hospitalization required until wounds are closed

Exclusion Criteria:

- Known hypersensitivity to products

- Outpatient treatment for burn injury

Locations and Contacts

University of Texas Medical Branch, Galveston, Texas 77555, United States
Additional Information

Starting date: July 1995
Last updated: December 10, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017